Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced cholestasis.

S Chitturi1, G C Farrell

  • 1Storr Liver Unit, Westmead Millennium Institute, University of Sydney, Westmead Hospital, New South Wales, Australia.

Seminars in Gastrointestinal Disease
|May 16, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Causes and mechanisms of adipocyte enlargement and adipose expansion.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2017
Same author

Week 4 viral load predicts long-term suppression of hepatitis B virus DNA during antiviral therapy: improving hepatitis B treatment in the real world.

Internal medicine journal·2016
Same author

Management of diabetes in Indigenous communities: lessons from the Australian Aboriginal population.

Internal medicine journal·2016
Same author

Glatiramer acetate induced hepatotoxicity.

Current drug safety·2012
Same author

PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.

British journal of cancer·2012
Same author

Infliximab-induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolate.

Inflammatory bowel diseases·2011
Same journal

Surgical management of gallstone disease and postoperative complications.

Seminars in gastrointestinal disease·2004
Same journal

Endoscopic and radiologic management of pancreatic and biliary tract diseases.

Seminars in gastrointestinal disease·2004
Same journal

Tumors of the gallbladder, bile ducts, and ampulla.

Seminars in gastrointestinal disease·2004
Same journal

Motility and dysmotility of the biliary tract.

Seminars in gastrointestinal disease·2004
Same journal

Primary sclerosing cholangitis.

Seminars in gastrointestinal disease·2004
Same journal

Gallbladder polyps, cholesterolosis, adenomyomatosis, and acute acalculous cholecystitis.

Seminars in gastrointestinal disease·2004
See all related articles

Drug-induced cholestasis, ranging from reversible forms to vanishing bile duct syndrome, can be caused by various medications and herbal remedies. Treatment focuses on drug withdrawal and supportive care, with liver transplant referral for severe cases.

Area of Science:

  • Hepatology
  • Clinical Pharmacology

Background:

  • Drug-induced liver injury (DILI) encompasses a spectrum of cholestatic conditions.
  • Understanding the diverse range of offending agents is crucial for diagnosis and management.

Observation:

  • Cholestasis can manifest as reversible forms or chronic vanishing bile duct syndrome.
  • Numerous drug classes, including antibiotics, steroids, and cardiovascular agents, are implicated.
  • Emerging concerns include newer macrolides, fluoroquinolones, statins, and herbal remedies.

Findings:

  • Specific human leukocyte antigen (HLA) profiles are associated with cholestasis from certain drugs like amoxicillin-clavulanate.
  • Genetic predispositions may influence susceptibility to drug-induced cholestasis.
  • The mechanistic role of these genetic associations is under investigation.

Related Experiment Videos

Implications:

  • Immediate withdrawal of the causative agent is the cornerstone of management.
  • Supportive therapies include cholestyramine, ursodeoxycholic acid, and nutritional support.
  • Prompt liver transplant evaluation is vital for patients with progressive disease, biliary cirrhosis, or liver failure.